Taiwan Biomaterial Co., Ltd. (TPEX:6649)
Taiwan · Delayed Price · Currency is TWD 37.50
-0.40 (-1.06%)
Jul 30, 2026, 1:30 PM CST
Taiwan Biomaterial Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 179.17 | 220.4 | 96.57 | 72.84 | 127.31 | 41.67 |
Revenue Growth | 23.12% | 128.22% | 32.59% | -42.79% | 205.48% | 130.56% |
Gross Profit Gross Profit Growth | 103.5 | 134.8 | 57.31 | 47.12 | 90.37 | 32.15 |
Operating Income Operating Income Growth | 26.64 | 60.83 | -11.24 | -14.23 | 25.46 | -56.72 |
Net Income Net Income Growth | 26.02 | 58.93 | -1.73 | -10.13 | 33.76 | -47.44 |
Earnings Per Share EPS Growth | 0.61 | 1.40 | -0.04 | -0.24 | 0.83 | -1.44 |
EPS Growth | -20.18% | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | 177.6 | 217.85 | 89.58 | 70.45 | 124.76 | 38.34 |
Taiwan Taiwan Growth | - | 2.55 | 6.99 | 2.39 | 2.55 | 3.34 |
Total Total Growth | 179.17 | 220.4 | 96.57 | 72.84 | 127.31 | 41.67 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 305.73 | 355.91 | 312.84 | 304.18 | 332.65 | 152.65 |
Total Debt Total Debt Growth | 51.48 | 52.59 | 56.99 | 60.7 | 68.51 | 73.92 |
Net Cash (Debt) Net Cash Growth | 254.25 | 303.32 | 255.85 | 243.48 | 264.14 | 78.73 |
Net Cash Growth | -11.88% | 18.55% | 5.08% | -7.82% | 235.51% | -40.61% |
Net Cash Per Share Net Cash Per Share Growth | 6.05 | 7.22 | 6.09 | 5.80 | 6.46 | 2.39 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 17.81 | 48.77 | 18.43 | -10.16 | 29.31 | -26.29 |
Capital Expenditures CapEx Growth | -2.65 | -1.44 | -3.69 | -2.57 | -35.67 | -28.01 |
Free Cash Flow Free Cash Flow Growth | 15.16 | 47.33 | 14.74 | -12.74 | -6.36 | -54.3 |
Free Cash Flow Growth | -74.09% | 221.06% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 57.77% | 61.16% | 59.34% | 64.69% | 70.99% | 77.15% |
Operating Margin | 14.87% | 27.60% | -11.63% | -19.53% | 20.00% | -136.10% |
Pretax Margin | 14.52% | 26.74% | -2.58% | -12.40% | 26.51% | -113.84% |
Profit Margin | 14.52% | 26.74% | -1.79% | -13.91% | 26.52% | -113.84% |
FCF Margin | 8.46% | 21.47% | 15.26% | -17.49% | -5.00% | -130.31% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.000 | 1.000 | - | - | 0.200 |
Dividend Per Share Growth | 0% | - | - | - | - |
Dividend Yield | 2.69% | 2.20% | - | - | 0.59% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 61.83 | 33.14 | - | - | 43.18 | - |
P/FCF Ratio | 105.00 | 41.27 | 97.44 | - | - | - |
PS Ratio | 8.88 | 8.86 | 14.87 | 18.05 | 11.45 | 19.64 |